Test Lists

  • Regression Package Testing List Page
Publisher QA3 - UPP Test
  • Regression Package Testing List Page
1 / 0

Amgen Canada Launches My HeartPath(TM) – An App for Every Heart Attack Recovery Journey

November 3, 2020
By Amgen Canada
Alt Text FF - Home Screen Icon 3
Caption FF
Description FF
Share this...
  • Facebook
  • Pinterest
  • Twitter
  • Linkedin

MISSISSAUGA, ON, Nov. 3, 2020 /CNW/ – Amgen Canada Inc. (Amgen Canada) has partnered with patients and healthcare professionals to launch the global pilot of My HeartPathTM in Canada. My HeartPathTM is a heart health app which supports and empowers patients during their heart attack recovery.  

Amgen Canada logo (CNW Group/Amgen Canada)

My HeartPathTM is the first of its kind in Canada for heart attack survivors and provides practical advice, educational resources and support for patients who have suffered devastating heart attacks.

Working with patients and healthcare providers allowed Amgen Canada to understand the depth of patient needs during their heart attack recovery and the problems that My HeartPathTM needed to solve. These insights became central to the app’s development, with patient experience and feedback driving functionality and capability of the app.

Dr. Beth Abramson, Director of the Cardiac Prevention and Rehabilitation Centre at St Michael’s Hospital in Toronto, Canada was a central part of the design team. Abramsom said enabling the providers of care to give insight into how the patients go through their recovery process was invaluable. 

“I’m truly hopeful My HeartPathTM will improve care as we integrate modern technology into the healing and secondary prevention path for our patients, addressing factors like wellness, risk factor modification to improve care,” says Abramson.

My HeartPathTM addresses common patient pain points during heart attack recovery by providing solutions in key moments which matter. These pain points, such as intangible goals and a lack of meaningful information, are solved by the functionality built into the app.

Patricia van den Ende, a heart attack survivor who was also involved in the development of the app, says that life after a heart attack can be complicated. “It’s a long journey and there’s a lot of things that you need to do try to prevent a second heart attack. My HeartPathTM helps to make it easy for survivors and provides information and motivation that you need, when you need it.”

My HeartPathTM provides an overview of not only short-term goals but also the bigger picture – what patients are working toward in 3 months, 6 months or a year. It also includes a number of features, allowing patients to maximize visits with their doctors – this includes reminders, medication prompts and an LDL tracker. Lastly, it enables clear goal setting to encourage healthy habits in the short and long term. 

“My HeartPathTM is designed for patients by patients, Healthcare Providers and Amgen Canada. At Amgen Canada our mission is to serve patients, and we’re proud to bring the global pilot of My HeartPathTM to Canadians, supporting them and empowering them during their recovery journey” says Dr. Suna Avcil, Executive Medical Director at Amgen Canada.

“This heart health app will offer patients who have suffered a heart attack more support during their recovery journey. It will benefit thousands of patients who have ASCVD or other forms of cardiovascular disease, empowering them to take control of their own recovery after a heart attack,” says Dr. Beth Abramsom, Preventative Cardiologist.

My HeartPathTM can be downloaded on the App Store or on Google Play

To learn more about My HeartPathTM visit MyHeartPathApp.ca

About Amgen Canada 
As a leader in innovation, Amgen Canada understands the value of science. With main operations located in Mississauga, ON’s vibrant biomedical cluster, and its research facility in Burnaby, B.C., Amgen Canada has been an important contributor to advancements in science and innovation in Canada since 1991. The company contributes to the development of new therapies and new uses for existing medicines in partnership with many of Canada’s leading healthcare, academic, research, government and patient organizations. To learn more about Amgen Canada, visit www.amgen.ca and follow us on www.twitter.com/amgencanadagm.

Categories: Madison Magazine Logo

Latest Stories

Eu Regulator Authorizes Astrazeneca Vaccine For All Adults

EU regulator authorizes AstraZeneca vaccine for all adults

Rayos Syndication User,
KXLY-Latest Stories

Regulators authorized AstraZeneca’s coronavirus vaccine for use in adults throughout the European Union on Friday, amid criticism the bloc is not moving fast enough to vaccinate its population.

Ex Fbi Lawyer Given Probation For Russia Probe Actions

Ex-FBI lawyer given probation for Russia probe actions

Rayos Syndication User,
KXLY-Latest Stories

WASHINGTON (AP) — A former FBI lawyer was sentenced to probation for altering an email that the Justice Department relied on during its surveillance of an aide to President Donald Trump during the Russia investigation.

Evers: Repealing Mask Mandate Like Eliminating Speed Limits

Evers: Repealing mask mandate like eliminating speed limits

Rayos Syndication User,
KXLY-Latest Stories

MADISON, Wis. (AP) — Democratic Gov. Tony Evers lashed out Friday at rival Republicans who tried to repeal his statewide mask mandate, saying killing the order would be a ridiculous move comparable to abolishing speed limits.

Conservatives Praise South Carolina Win On Abortion Ban

Conservatives praise South Carolina win on abortion ban

Rayos Syndication User,
KXLY-Latest Stories

COLUMBIA, S.C. (AP) — As some conservatives in South Carolina celebrated getting a bill that would ban almost all abortions in the state past a legislative barrier and likely becoming law, they said they are not finished trying to end all abortions.

Moscow Court Puts Navalny’s Allies Under House Arrest

Moscow court puts Navalny's allies under house arrest

Rayos Syndication User,
KXLY-Latest Stories

A Moscow court on Friday put the brother and several allies of Russian opposition leader Alexei Navalny under house arrest for two months as authorities sought to stymie more protests over the jailing of the top Kremlin foe.

Most Popular

9:40 Future Import Test

One more current test NW

Current UPP Import NW

Test New Article 12092025 - 4 - Message

Test New Article 12092025 - 4 - Election

Test New Article 12092025 - 2 - Closing

© 2026 Publisher QA3 – UPP Test.

Privacy Policy
Powered byBLOX Digital
X